Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
利用水凝胶支架设计适应性免疫反应以促进组织再生
基本信息
- 批准号:10343752
- 负责人:
- 金额:$ 63.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-02 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Accidental InjuryAdaptive Immune SystemAgeAmericanAmino AcidsAntibodiesAntibody FormationAntigensB-LymphocytesBiocompatible MaterialsBiologicalBiological AssayCD3 AntigensCD4 Positive T LymphocytesCD8B1 geneCellsChemicalsCicatrixCrosslinkerDepositionDiabetes MellitusDiseaseEngineeringExtracellular MatrixFibrosisFlow CytometryGoalsGrantGrowth FactorHair follicle structureHealth Care CostsHealthcare SystemsHelper-Inducer T-LymphocyteHydrogelsITGAM geneIgG1Immune responseImmune signalingImmune systemImmunityImmunohistochemistryImplantIn SituInfiltrationInflammationInnate Immune ResponseInnate Immune SystemInvestigationKnockout MiceLeadLinkMediatingModificationMusNatural regenerationOperative Surgical ProceduresPatientsPeptidesPhenotypePopulationPorosityProcessProductionReportingReverse Transcriptase Polymerase Chain ReactionRoleScheduleSebaceous GlandsSignal TransductionSkinSkin TissueSpleenStainsStructureSweat GlandsT-LymphocyteTensile StrengthTestingTimeTissuesTriageTumor stageadaptive immune responsebasebiomaterial compatibilitybioscaffoldcapsulecostcrosslinkdraining lymph nodeenantiomerfunctional losshealinghydrogel scaffoldimmune activationimplant materialimplantationimprovedmacrophageparticlepeptide Lpreventrecruitregenerativeregenerative repairrepairedresponserestorationscaffoldskin regenerationstem cell growthstem cell therapysubcutaneoussuccesstissue regenerationtissue repairtissue support framewoundwound closurewound healingwound treatment
项目摘要
Summary
Biomaterial scaffolds represent a promising approach for material-based tissue regeneration. We previously
developed microporous annealed particle (MAP) hydrogels - a flowable, microparticle-based hydrogel in which
neighboring hydrogel particles are linked in situ to form a porous scaffold that accelerates wound healing.
Recently, we found that a relatively simple modification to the crosslinker peptide from L-enantiomer to D-
enantiomer resulted in substantial skin regeneration and that this regeneration only occurs when the adaptive
immune system is intact. Further investigation revealed that although D-chiral peptides were poor activators of
macrophage innate immune signaling, D-chiral peptides within MAP (D-MAP) elicited significant antigen-specific
immunity. In this proposal, we will further investigate the ability of our D-MAP material to activate the adaptive
immune system and lead to skin tissue regeneration. Aim 1 will focus on further understanding any role of the
innate immune system and the ability of MAP scaffold microstructure to dictate macrophage phenotype. Aim 2
will focus on testing our hypothesis that the adaptive immune system is activated by our material and leads to
regenerative wound healing. Aim 3 will investigate other biomaterial approaches to present D-peptides and
further control immune system activation.
概括
生物材料支架代表了基于材料的组织再生的一种有前途的方法。我们之前
开发了微孔退火颗粒(MAP)水凝胶 - 一种可流动的、基于微粒的水凝胶,其中
相邻的水凝胶颗粒原位连接形成多孔支架,加速伤口愈合。
最近,我们发现交联肽从 L-对映体到 D-对映体的相对简单的修饰
对映异构体导致大量皮肤再生,并且这种再生仅在适应性
免疫系统完好无损。进一步的研究表明,虽然 D-手性肽是较差的激活剂
巨噬细胞先天免疫信号,MAP 内的 D-手性肽 (D-MAP) 引发显着的抗原特异性
免疫。在本提案中,我们将进一步研究 D-MAP 材料激活自适应能力的能力
免疫系统并导致皮肤组织再生。目标 1 将侧重于进一步了解
先天免疫系统和 MAP 支架微结构决定巨噬细胞表型的能力。目标2
将重点测试我们的假设,即适应性免疫系统被我们的材料激活并导致
伤口再生愈合。目标 3 将研究其他生物材料方法来呈现 D 肽和
进一步控制免疫系统的激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joel H Collier其他文献
Joel H Collier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joel H Collier', 18)}}的其他基金
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
用于调节补体系统炎症特性的超分子生物材料
- 批准号:
10538835 - 财政年份:2022
- 资助金额:
$ 63.94万 - 项目类别:
Supramolecular biomaterials for tuning the inflammatory properties of the complement system
用于调节补体系统炎症特性的超分子生物材料
- 批准号:
10631187 - 财政年份:2022
- 资助金额:
$ 63.94万 - 项目类别:
Engineered immunotherapies neutralizing interleukin-22 binding protein
中和白细胞介素 22 结合蛋白的工程免疫疗法
- 批准号:
10688059 - 财政年份:2022
- 资助金额:
$ 63.94万 - 项目类别:
Engineered immunotherapies neutralizing interleukin-22 binding protein
中和白细胞介素 22 结合蛋白的工程免疫疗法
- 批准号:
10538770 - 财政年份:2022
- 资助金额:
$ 63.94万 - 项目类别:
Sublingual Supramolecular Vaccines and Immunotherapies
舌下超分子疫苗和免疫疗法
- 批准号:
10671694 - 财政年份:2021
- 资助金额:
$ 63.94万 - 项目类别:
Supramolecular peptide immunotherapies for peanut allergy
花生过敏的超分子肽免疫疗法
- 批准号:
10416075 - 财政年份:2021
- 资助金额:
$ 63.94万 - 项目类别:
Supramolecular peptide immunotherapies for peanut allergy
花生过敏的超分子肽免疫疗法
- 批准号:
10317230 - 财政年份:2021
- 资助金额:
$ 63.94万 - 项目类别:
Sublingual Supramolecular Vaccines and Immunotherapies
舌下超分子疫苗和免疫疗法
- 批准号:
10390493 - 财政年份:2021
- 资助金额:
$ 63.94万 - 项目类别:
Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
利用水凝胶支架设计适应性免疫反应以促进组织再生
- 批准号:
10571804 - 财政年份:2020
- 资助金额:
$ 63.94万 - 项目类别:
Engineering Adaptive Immune Responses from Hydrogel Scaffolds to Promote Tissue Regeneration
利用水凝胶支架设计适应性免疫反应以促进组织再生
- 批准号:
10117193 - 财政年份:2020
- 资助金额:
$ 63.94万 - 项目类别:
相似国自然基金
转录因子LeuO激活适应性免疫系统CRISPR/Cas防御大肠杆菌自然转化的机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:面上项目
适应性免疫系统的发育和应答
- 批准号:
- 批准年份:2020
- 资助金额:400 万元
- 项目类别:国家杰出青年科学基金
肠道共生细菌与七鳃鳗可变淋巴细胞受体VLRA、VLRC交联对话( Cross-talk)机制研究
- 批准号:31500106
- 批准年份:2015
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
不同年龄牦牛免疫系统发育特征及其对高原环境的适应机制
- 批准号:31572478
- 批准年份:2015
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 63.94万 - 项目类别:
Contribution of Vitamin D Deficiency to Pathological Progression in Models of Cerebral Hypoperfusion
维生素 D 缺乏对脑低灌注模型病理进展的影响
- 批准号:
10725358 - 财政年份:2023
- 资助金额:
$ 63.94万 - 项目类别:
Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation
组织衰老和年龄相关的代谢功能障碍:免疫细胞介导的炎症的作用
- 批准号:
10585818 - 财政年份:2023
- 资助金额:
$ 63.94万 - 项目类别:
Preclinical validation of small molecule immunomodulators for the treatment of Crohn's disease
小分子免疫调节剂治疗克罗恩病的临床前验证
- 批准号:
10600659 - 财政年份:2023
- 资助金额:
$ 63.94万 - 项目类别: